Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -876,274 | -1,392,843 | -4,353,741 | -2,065,825 |
| Amortization of debt discount | 729,897 | 790,014 | 518,413 | 57,864 |
| Depreciation and amortization expense | 97,694 | 98,343 | 76,078 | 106,646 |
| Changes in the fair value of derivative liability | 1,084,492 | 921,028 | -863 | -1,477 |
| Common shares issued for conversion of note | NaN | 22,800 | NaN | NaN |
| Loss on extinguishment of debt | NaN | 0 | -416,155 | NaN |
| Preferred shares issued with debt | NaN | 0 | 0 | 401 |
| Accounts receivable | -8,994 | -70,191 | 77,330 | 14,071 |
| Prepaid expenses | 108,303 | 8,086 | -100,000 | 105,179 |
| Other assets | NaN | 5,274 | 20,000 | 0 |
| Inventory | 138,924 | 3,391 | 50,198 | 95,573 |
| Accounts payable and accrued liabilities | 1,473,532 | 1,387,470 | 3,186,028 | 1,573,277 |
| Cash provided by operating activities | 102,124 | 38,196 | -203,731 | -540,984 |
| Purchase of property and equipment | 315,394 | 267,172 | 224,829 | 110,582 |
| Cash used by investing activities | -315,394 | -267,172 | -224,829 | -110,582 |
| Proceeds from issuance of debt | 318,000 | 0 | 0 | 1,100,000 |
| Cash provided by financing activities | 318,000 | 0 | 0 | 1,100,000 |
| Net increase in cash | 104,730 | -228,977 | -428,559 | 448,434 |
| Cash, beginning of period | 956,718 | 1,185,695 | 1,165,820 | NaN |
| Cash, end of period | 1,061,448 | 956,718 | 1,185,695 | NaN |